Related Experiment Video
Updated: May 23, 2026

07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Optimizing clozapine through clinical decision making
1VA Connecticut Healthcare System, Clinical Epidemiology Research Center, West Haven, CT 06516, USA. paul.falzer@yale.edu
Acta Psychiatrica Scandinavica
|April 19, 2012
Summary
Incorporating patient perspective is key for optimizing clozapine treatment. Clinicians
Area of Science:
- Psychiatry
- Clinical Decision-Making
- Pharmacotherapy
Background:
- Optimizing clozapine use requires integrating patient insights into treatment decisions.
- Clinicians' decision-making strategies are influenced by patient perspectives.
Purpose of the Study:
- To investigate how patient perspectives impact clinicians' decision strategies and clozapine recommendations.
- To analyze the interplay between clinical information and patient views in treatment planning.
Main Methods:
- Psychiatric trainees evaluated case vignettes with clinical and patient data.
- Treatment recommendations were made using a switching guideline, and influencing factors were rated.
Main Results:
- Patient's positive symptom profile primarily influenced guideline adherence for switching.
- Patient perspective and clinical data significantly impacted clozapine recommendation rates.
- When clinical factors were highly important, patient perspective's importance strongly correlated with higher clozapine recommendation rates (8% to 80%).
Conclusions:
- Clozapine optimization necessitates advanced decision-making, balancing patient perspective with clinical data.
- Prioritizing patient views is crucial without overshadowing clinical evidence.
- Practice-based learning can enhance clinicians' skills in integrating patient perspectives for better clozapine management.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
